Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats

Table 2 IL-23 and TNF-α levels in rat serum in oxazolone-induced experimental colitis

Group (n = 7)	Dose	IL-23 (ng/L)	TNF-α(ng/L)
NC	N/A	5.75 ± 2.51	15.93 ± 11.36
PC	N/A	43.94 ± 20.36d	28.17 ± 6.10c
PB	2.3 × 1011 CFU/L	5.99 ± 1.88b	16.05 ± 10.54a
MA	100 g/L	8.81 ± 3.78b	23.54 ± 11.03
SB	0.05 mol/L	8.38 ± 4.48b	23.18 ± 6.48

^aP < 0.05,

^bP < 0.01 vs PC;

^cP < 0.05,

^dP < 0.01 vs NC. PC: Positive control; NC: Negative control; PB: Probiotic (C. butyricum); MA: Mesalamine; SB: Sodium butyrate.